Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study ; volume:23 ; number:1 ; day:17 ; month:10 ; year:2023 ; pages:1 ; date:12.2023
BMC pulmonary medicine ; 23, Heft 1 (17.10.2023), 1, 12.2023
- Urheber
-
Al Sulaiman, Khalid
Aljuhani, Ohoud
Korayem, Ghazwa B.
Altebainawi, Ali F.
Alharbi, Reham
Assadoon, Maha
Vishwakarma, Ramesh
Ismail, Nadia H.
Alshehri, Asma A.
Al Mutairi, Faisal E.
AlFaifi, Mashael
Alharthi, Abdullah F.
Alenazi, Abeer A.
Alalawi, Mai
Al Zumai, Omar
Al Haji, Hussain
Al Dughaish, Sarah T.
Alawaji, Abdulrahman S.
Alhaidal, Haifa A.
Al Ghamdi, Ghassan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-023-02687-y
- URN
-
urn:nbn:de:101:1-2024013114311432346418
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al Sulaiman, Khalid
- Aljuhani, Ohoud
- Korayem, Ghazwa B.
- Altebainawi, Ali F.
- Alharbi, Reham
- Assadoon, Maha
- Vishwakarma, Ramesh
- Ismail, Nadia H.
- Alshehri, Asma A.
- Al Mutairi, Faisal E.
- AlFaifi, Mashael
- Alharthi, Abdullah F.
- Alenazi, Abeer A.
- Alalawi, Mai
- Al Zumai, Omar
- Al Haji, Hussain
- Al Dughaish, Sarah T.
- Alawaji, Abdulrahman S.
- Alhaidal, Haifa A.
- Al Ghamdi, Ghassan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
Critically ill severe hypothyroidism: a retrospective multicenter cohort study
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
Critically ill severe hypothyroidism: a retrospective multicenter cohort study
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients
Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study
Methylprednisolone in the treatment of lymphangioleiomyomatosis
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
Critically ill severe hypothyroidism: a retrospective multicenter cohort study